Global Longlife Hospital and Research Ltd (GLHRL)

Loading page…

Global Longlife Hospital and Research Ltd (GLHRL) · mywealthgrid

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Max Healthcare Institute LimitedMAXHEALTHMAXHEALTH	₹91,573 Cr	₹95,052 Cr	₹8,712 Cr	₹2,318 Cr	26.8%	₹1,457 Cr	17.2%	13.8%	14.3%	-110
Manipal Health Enterprises LimitedMANIPALHOSMANIPALHOS	₹91,552 Cr	₹1,02,105 Cr	₹10,336 Cr	₹2,611 Cr	25.3%	₹917 Cr	8.9%	12.5%	12.8%	38
Fortis Healthcare LimitedFORTISFORTIS	₹59,268 Cr	₹62,140 Cr	₹9,506 Cr	₹2,131 Cr	22.8%	₹1,048 Cr	11.7%	13%	11.1%	-99
Aster Dm Healthcare LimitedASTERDMASTERDM	₹36,728 Cr	₹37,429 Cr	₹4,876 Cr	₹958 Cr	19.4%	₹319 Cr	9.2%	11.9%	9.7%	-112
Global Health LimitedMEDANTAMEDANTA	₹36,498 Cr	₹37,688 Cr	₹4,683 Cr	₹979 Cr	20.8%	₹556 Cr	12.6%	16.9%	15.1%	-26
Narayana Hrudayalaya Ltd.NHNH	₹35,594 Cr	₹40,460 Cr	₹9,072 Cr	₹1,749 Cr	20.5%	₹816 Cr	10.2%	15.1%	19.7%	-181
Krishna Institute Of Medical Sciences LimitedKIMSKIMS	₹29,457 Cr	₹32,701 Cr	₹4,213 Cr	₹833 Cr	20.5%	₹205 Cr	6.2%	9.5%	11%	-50
Dr. Agarwal's Health Care LimitedAGARWALEYEAGARWALEYE	₹15,420 Cr	₹15,578 Cr	₹2,207 Cr	₹612 Cr	27.4%	₹148 Cr	8.1%	10.1%	6.8%	-76
Rainbow Childrens Medicare LimitedRAINBOWRAINBOW	₹13,003 Cr	₹13,003 Cr	₹1,820 Cr	₹575 Cr	32%	₹285 Cr	16.5%	18.2%	17.9%	-73
Park Medi World LimitedPARKHOSPSPARKHOSPS	₹11,696 Cr	₹11,924 Cr	₹1,679 Cr	₹444 Cr	26.5%	₹258 Cr	16.3%	21.4%	16.7%	-2
Healthcare Global Enterprises LimitedHCGHCG	₹9,984 Cr	₹10,895 Cr	₹2,627 Cr	₹480 Cr	18.3%	₹23 Cr	0.9%	9.1%	1.2%	-93
Yatharth Hospital & Trauma Care Services LimitedYATHARTHYATHARTH	₹9,965 Cr	₹10,218 Cr	₹1,334 Cr	₹310 Cr	24.2%	₹174 Cr	14.1%	12.3%	10%	-26

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Standalone figures · ₹ crore

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	33	24	14	1	0
COGS	4	4	8	0	0
Gross profit	29	19	5	0	—
	21	15	5	4	1
Operating profit (EBITDA)	8	4	-0	-4	-1
OPM %	24.5%	17.2%	-2.3%	-715.5%	—
Depreciation	1	1	1	0	0
Interest	1	0	1	0	0
	0	0	0	5	0
Profit before tax	6	3	-2	0	-1
Tax	2	1	-0	-0	1
Tax %	37.5%	32.5%	-3.5%	-100%	73.7%
	4	2	-2	0	-2
PAT margin %	10.9%	7.8%	-16.2%	34.5%	—
EPS (₹)	5.1	1.8	-2.1	0.2	1.6
Annual report	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	—	—	—	—	—
Reserves	—	—	—	—	—
Borrowings	—	—	—	—	—
	34	76	42	27	24
Total equity & liabilities	34	76	42	27	24
Fixed assets	—	—	—	0	0
CWIP	—	—	—	—	—
Investments	0	0	0	0	0
	34	76	42	27	24
Total assets	34	76	42	27	24

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	9	-40	-5	12	-5
	0	-2	-1	22	0
	-10	46	3	-13	0
Net cash flow	-0	3	-3	21	-4
Free cash flow	9	-42	-6	12	-5
CFO / Operating profit %	117.3%	—	—	—	—

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Standalone figures

Ratio	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	89%	81.6%	37.4%	24.1%	—
EBITDA margin %	24.5%	17.2%	-2.3%	-715.5%	—
EBIT margin %	21%	12.2%	-11.5%	-798.3%	—
PAT margin %	10.9%	7.8%	-16.2%	34.5%	—
Working capital
Receivable days	—	—	—	—	—
Inventory days	89	69	19	0	—
Payable days	—	—	—	—	—
NWC days	—	—	—	—	—
Leverage
Current ratio	0.82	4.28	0.32	377.33	2,029
Debt to EBITDA	—	—	—	—	—
Debt to equity	—	—	—	—	—
Interest coverage	5.1	7.8	-1.9	1.4	—
Asset turnover	0.97	0.31	0.32	0.02	0
Return ratios
Return on assets %	10.5%	2.4%	-5.2%	0.7%	-7.2%
Return on capital employed %	35.2%	7%	-3.1%	1.4%	-3.9%
Return on equity %	—	—	—	—	—

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	54.29%	54.29%	54.29%	54.9%	55.1%	35.44%	22.88%	22.88%
FII	0%	0%	0%	0%	0%	0%	0%	0%
DII	0%	0%	0%	0%	0%	0%	0%	0%
Government	0%	0%	0%	0%	0%	0%	0%	0%
	45.71%	45.71%	45.71%	45.1%	44.9%	64.56%	77.12%	77.12%
No. of shareholders	974	989	938	917	915	985	1,149	1,133

Promoter holding down 31.41 percentage points since Sep 2024.

38 deals · 6 Aug 2026 – 30 Sept 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
30 Sept 2026	ALACRITY SECURITIES LIMITED	Bulk	BSE	Buy	1,00,000	₹12.74	₹0.13 Cr
30 Sept 2026	ABHISHEK ASHVINBHAI KAMDAR HUF	Bulk	BSE	Sell	69,000	₹12.76	₹0.09 Cr
28 Sept 2026	ABHISHEK ASHVINBHAI KAMDAR HUF	Bulk	BSE	Sell	3,46,000	₹13.39	₹0.46 Cr
28 Sept 2026	DIPEN MUKESHBHAI BAROT	Bulk	BSE	Sell	3,39,000	₹14.70	₹0.50 Cr
28 Sept 2026	KANTABEN JAYANTILAL KORADIYA	Bulk	BSE	Sell	1,98,000	₹14.70	₹0.29 Cr
28 Sept 2026	JAYDIPKUMARVALLABHBHAIKHUNT	Bulk	BSE	Buy	1,36,000	₹14.70	₹0.20 Cr
28 Sept 2026	ABHISHEK ASHVINBHAI KAMDAR	Bulk	BSE	Buy	1,00,000	₹14.68	₹0.15 Cr
28 Sept 2026	VIPUL AVANTILAL SHAH	Bulk	BSE	Buy	1,00,000	₹13.30	₹0.13 Cr
28 Sept 2026	ATRICHHAYA FINANCIAL PRIVATE LIMITED	Bulk	BSE	Sell	88,000	₹14.60	₹0.13 Cr
28 Sept 2026	DIPAKKUMAR M DANGAR	Bulk	BSE	Buy	68,000	₹14.70	₹0.10 Cr

1–10 of 38

1 / 4

Dhruv JaniManaging Director
Sucheta JaniNon Executive Director
Manasvi ThaparIndependent Director
Ms. Hetal ThakkarExecutive Director
Mr. Hiren MandaliyaNon - Executive Independent Director
Ms. Tanvi SolankiCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

Ratio	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	89%	81.6%	37.4%	24.1%	—
EBITDA margin %	24.5%	17.2%	-2.3%	-715.5%	—
EBIT margin %	21%	12.2%	-11.5%	-798.3%	—
PAT margin %	10.9%	7.8%	-16.2%	34.5%	—
Working capital
Receivable days	—	—	—	—	—
Inventory days	89	69	19	0	—
Payable days	—	—	—	—	—
NWC days	—	—	—	—	—
Leverage
Current ratio	0.82	4.28	0.32	377.33	2,029
Debt to EBITDA	—	—	—	—	—
Debt to equity	—	—	—	—	—
Interest coverage	5.1	7.8	-1.9	1.4	—
Asset turnover	0.97	0.31	0.32	0.02	0
Return ratios
Return on assets %	10.5%	2.4%	-5.2%	0.7%	-7.2%
Return on capital employed %	35.2%	7%	-3.1%	1.4%	-3.9%
Return on equity %	—	—	—	—	—

Date	Category	Subject	Filing
30 Sept 2026, 3:07 pm	Insider Trading / SAST Closure of Trading Window	Closure of Trading Window	PDF
28 Sept 2026, 6:16 pm	Company Update General	Intimation Regarding Alteration In Name Of The Company Pursuant To Approval Of Registrar Of Companies	PDF

Global Longlife Hospital and Research Ltd

About

Quick read

Pros

Cons

Revenue & net profit

Margins

Peers

Financials

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

No events on record

Announcements

No events on record

Not in the F&O segment

No fund holdings on record

Announcements

Annual reports

Global Longlife Hospital and Research Ltd

About

Quick read

Pros

Cons

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

No events on record

Announcements

No events on record

Ratio timeline

Not in the F&O segment

No fund holdings on record

Quarterly record

Bulk & block deals

Board and management

Announcements

Annual reports

Profit & loss

Balance sheet

Cash flow